Pallas Capital Advisors LLC Catalent, Inc. Transaction History

Pallas Capital Advisors LLC

  • $2.32 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 01, 2022
SELL
$119.57 - $139.07 $188,681 - $219,452
-1,578 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$109.17 - $142.35 $30,240 - $39,430
-277 Reduced 14.93%
1,578 $215,000
Q2 2021

Aug 11, 2021
BUY
$100.34 - $115.69 $186,130 - $214,604
1,855 New
1,855 $228,000

Others Institutions Holding CTLT

# of Institutions
489
Shares Held
165M
Call Options Held
364K
Put Options Held
837K
View Full List

About Catalent, Inc.

CTLT Quotes by TradingView
  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.9B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Pallas Capital Advisors LLC Portfolio

Follow Pallas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pallas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pallas Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email